介素-1α抑制剂梅克利米马布在阿托皮性皮肤炎患者:随机和非随机研究
Eric L Simpson1, Emma Guttman-Yassky2, Jeffrey Pawlikowski3
1Oregon Health & Science University, South Waterfront, 3303 S. Bond Ave, Portland, OR, 97239, USA. simpsone@ohsu.edu.
Archives of dermatological research
|August 30, 2024
概括
伯梅基马布是一种介素-1α抑制剂,在早期试验中显示出对亚托皮炎 (AD) 的初步承诺. 然而,较大的受控研究未能证实其有效性,导致一些试验提前终止.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病.
- 互乐金-1α (IL-1α) 在AD病变发生过程中发挥作用.
- 柏梅基马布是一种向IL-1α的单克隆抗体.
研究的目的:
- 评估梅克西马布在中度至重度亚托皮性皮肤炎患者的疗效和安全性.
- 评估maketimab的药理动力学/药理动力学和分子效应,使用一种新的人类皮肤扩展模型.
主要方法:
- 四个第二阶段研究 (NCT03496974,NCT04021862,NCT04791319,NCT04990440) 涉及安慰剂控制,随机设计与皮下或静脉注射 bermekimab.
- 使用了一种新的人体外活体皮肤药理动力学试验.
- 研究包括剂量升级,剂量范围和活性比较器臂.
主要成果:
- 最初的开放标签研究 (研究1) 表明400毫克皮下 bermekimab.潜在的疗效.
- 较大的受控研究 (研究2,GENESIS) 没有证实这些疗效发现.
- 活体检测表明,bermekimab减少了下游皮肤损伤反应.
- 由于缺乏确定的疗效,GENESIS和LUNA研究被提前终止.
结论:
- 柏梅基马布在阿尔茨海默病早期研究中显示出潜力.
- 有控制的临床试验未能验证最初的有希望的结果.
- 根据这些发现,根据这些发现,停止了针对亚托邦性皮肤炎的me bermekimab的进一步开发.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
880
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
880
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627